Lotus Pharm vs TSH Biopharm: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and TSH Biopharm (8432) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ TSH Biopharm

0%+226%-36%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYTSH BiopharmYoY
Oct 2026NT$2.13 billion-22.5%NT$168.9 million+19.3%
Sep 2026NT$2.77 billion+128.0%NT$325.4 million+34.1%
Aug 2026NT$2.11 billion+81.7%NT$124.8 million+30.9%
Jul 2026NT$2.49 billion+3.9%NT$107 million+26.6%
Jun 2026NT$3.4 billion+225.5%NT$96.3 million+6.4%
May 2026NT$2.32 billion+105.8%NT$126.1 million+34.5%
Apr 2026NT$3.09 billion+19.9%NT$108.4 million+27.4%
Mar 2026NT$4.35 billion+173.6%NT$108.8 million+15.6%
Feb 2026NT$2.24 billion+131.5%NT$70 million-35.9%
Jan 2026NT$2.05 billion-5.5%NT$107 million+27.7%
Dec 2025NT$2.44 billion+66.9%NT$105.7 million+4.2%
Nov 2025NT$1.06 billion-0.2%NT$118 million+28.3%
Oct 2025NT$2.75 billion+46.0%NT$141.6 million+45.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16